Correlation Between Visa and Medivie Therapeutic
Can any of the company-specific risk be diversified away by investing in both Visa and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Medivie Therapeutic, you can compare the effects of market volatilities on Visa and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Medivie Therapeutic.
Diversification Opportunities for Visa and Medivie Therapeutic
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Medivie is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of Visa i.e., Visa and Medivie Therapeutic go up and down completely randomly.
Pair Corralation between Visa and Medivie Therapeutic
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.18 times more return on investment than Medivie Therapeutic. However, Visa Class A is 5.63 times less risky than Medivie Therapeutic. It trades about 0.08 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.02 per unit of risk. If you would invest 22,017 in Visa Class A on September 3, 2024 and sell it today you would earn a total of 9,491 from holding Visa Class A or generate 43.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 77.47% |
| Values | Daily Returns |
Visa Class A vs. Medivie Therapeutic
Performance |
| Timeline |
| Visa Class A |
| Medivie Therapeutic |
Visa and Medivie Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Medivie Therapeutic
The main advantage of trading using opposite Visa and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.| Visa vs. American Express | Visa vs. Capital One Financial | Visa vs. Upstart Holdings | Visa vs. Ally Financial |
| Medivie Therapeutic vs. Batm Advanced Communications | Medivie Therapeutic vs. Brainsway | Medivie Therapeutic vs. Mivne Real Estate | Medivie Therapeutic vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |